Arlo-cel (arlocabtagene autoleucel)- A GPRC5D-Directed CAR-T Therapy on the Horizon for Myeloma скачать в хорошем качестве

Arlo-cel (arlocabtagene autoleucel)- A GPRC5D-Directed CAR-T Therapy on the Horizon for Myeloma

Arlo-cel is an experimental CAR-T therapy targeting GPRC5D, a protein on myeloma cells. It reprograms a patient’s T cells to attack the cancer, offering hope for relapsed or resistant myeloma. This HealthTree University video will give you a brief update on this Therapy on the Horizon. If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.